The firm, formed by the merger of WuXi Healthcare Ventures and Frontline Bioventures, is raising a $26m affiliates fund according to a securities filing.

6 Dimensions Capital, the strategic investment vehicle formed by pharmaceutical firm WuXi PharmaTech and venture capital firm Frontline BioVentures, is raising up to $26m for an affiliates fund, according to a regulatory filing.

WuXi Healthcare Ventures, the corporate venture capital arm of WuXi PharmaTech, combined with Frontline in May 2017 to form US-based 6 Dimensions. The firm announced it was looking to raise $450m for its first US fund in October this year.

The affiliates fund is led by…